Article

Predicting Success of Phase III Trials in Oncology

2020-12-16

Abstract excerpt

We developed a model predicting the probability of success (PoS) for single planned or ongoing PhIII trials based on information available at trial initiation. Such a model is highly relevant for study sponsors to capture risk and opportunity on a trial to trial basis through trial optimization, and for investors to select drugs whose trial design match their investment strategy. <h4>Objectives:</h4> To predict th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 98ce886d-aeb6-5e7e-91f6-e01243322f86
DOI: 10.1101/2020.12.15.20248240

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predicting Success of Phase III Trials in OncologyDOI 10.1101/2020.12.15.20248240Read

SCOPE: Integrating Organoid Screening and Clinical Variables Through Machine Learning for Cancer Trial Outcome PredictionSemantic proximity Read

Predict progression free survival and overall survival using objective response rate for anti - PD1 / PDL1 therapy developmentSemantic proximity Read

Leveraging Machine Learning Models to Predict Probability of Technical and Regulatory SuccessSemantic proximity Read

Review of calculation of conditional power, predictive power and probability of success in clinical trials with continuous, binary and time-to-event endpointsSemantic proximity Read

Predicting Individual Responses in Phase I Oncology Trials Using Routinely Collected Clinical BiomarkersSemantic proximity Read

An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologySemantic proximity Read

Clinical Advancement ForecastingSemantic proximity Read

Machine learning model to predict oncologic outcomes for drugs in randomized clinical trials.Semantic proximity Read

Predicting clinically promising therapeutic hypotheses using tensor factorizationSemantic proximity Read

A Deep Learning Framework for Causal Inference in Clinical Trial Design: The CURE AI Large Clinicogenomic Foundation ModelSemantic proximity Read

End-of-life prognostic models in advanced cancer: a scoping review of model development, validation, and impactSemantic proximity Read

Success Rates and Timelines of African-Inclusive Phase III Trials: A Retrospective AnalysisSemantic proximity Read